Stock listing
NASDAQ:UNCY Unicycive Therapeutics, Inc. Stock
Home listing (NASDAQ) of Unicycive Therapeutics, Inc.
Follow Unicycive Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:UNCY
$3.74 USD -0.07 (-1.8%)
Close on Oct 30, 2026
- Day range
- $3.62 – $3.93 USDOct 30, 2026
- Volume
- 977,989 sharesOct 30, 2026
- Market cap
- $102.4M USDAt the close on Oct 30, 2026 · price × 27.39M shares outstanding
- 52-week range
- $3.35 – $8.74 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $4.10M USDMedian day 825,150 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:UNCY · Home | $3.74 USD | -0.07 (-1.8%) | 977,989 | $3.77 | $3.93 | $3.623 | $3.81 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:UNCY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.74 | -0.07 | -1.8% | $3.77 | $3.93 | $3.623 | 977,989 | |
| $3.81 | +0.05 | +1.3% | $3.815 | $3.87 | $3.74 | 891,630 | |
| $3.76 | +0.15 | +4.2% | $3.60 | $3.77 | $3.58 | 1,129,015 | |
| $3.61 | +0.03 | +0.8% | $3.60 | $3.69 | $3.48 | 1,340,066 | |
| $3.58 | -0.31 | -8.0% | $3.90 | $3.90 | $3.534 | 1,316,093 | |
| $3.89 | -0.05 | -1.3% | $3.95 | $4.017 | $3.705 | 1,212,400 | |
| $3.94 | +0.07 | +1.8% | $3.87 | $4.00 | $3.83 | 742,800 | |
| $3.87 | +0.07 | +1.8% | $4.08 | $4.18 | $3.825 | 1,437,900 | |
| $3.80 | +0.29 | +8.3% | $3.53 | $3.87 | $3.52 | 1,207,900 | |
| $3.51 | +0.15 | +4.5% | $3.37 | $3.64 | $3.355 | 1,126,600 | |
| $3.36 | -0.23 | -6.4% | $3.58 | $3.595 | $3.35 | 1,102,300 | |
| $3.59 | -0.11 | -3.0% | $3.70 | $3.708 | $3.56 | 893,000 | |
| $3.70 | -0.03 | -0.8% | $3.73 | $3.81 | $3.59 | 1,208,800 | |
| $3.73 | -0.32 | -7.9% | $3.99 | $4.02 | $3.67 | 1,836,600 | |
| $4.05 | -0.06 | -1.5% | $4.10 | $4.11 | $3.99 | 912,800 | |
| $4.11 | +0.04 | +1.0% | $4.07 | $4.20 | $4.05 | 551,400 | |
| $4.07 | -0.11 | -2.6% | $4.16 | $4.199 | $4.03 | 1,176,100 | |
| $4.18 | -0.05 | -1.2% | $4.15 | $4.22 | $4.08 | 590,700 | |
| $4.23 | +0.04 | +1.0% | $4.20 | $4.294 | $4.15 | 785,400 | |
| $4.19 | -0.03 | -0.7% | $4.22 | $4.275 | $4.12 | 681,400 | |
| $4.22 | -0.33 | -7.3% | $4.62 | $4.62 | $4.09 | 1,510,100 | |
| $4.55 | -0.145 | -3.1% | $4.71 | $4.76 | $4.545 | 1,068,800 | |
| $4.695 | +0.145 | +3.2% | $4.61 | $4.81 | $4.574 | 862,700 | |
| $4.55 | -0.09 | -1.9% | $4.66 | $4.70 | $4.28 | 2,306,600 | |
| $4.64 | -0.055 | -1.2% | $4.66 | $4.68 | $4.53 | 601,500 | |
| $4.695 | -0.115 | -2.4% | $4.83 | $4.85 | $4.66 | 494,100 | |
| $4.81 | 0.00 | 0.0% | $4.81 | $4.855 | $4.62 | 660,300 | |
| $4.81 | -0.15 | -3.0% | $4.94 | $4.96 | $4.73 | 771,800 | |
| $4.96 | +0.19 | +4.0% | $4.80 | $4.97 | $4.76 | 587,700 | |
| $4.77 | -0.03 | -0.6% | $4.85 | $4.85 | $4.745 | 448,400 | |
| $4.80 | +0.03 | +0.6% | $4.80 | $4.85 | $4.76 | 1,108,400 | |
| $4.77 | -0.01 | -0.2% | $4.86 | $4.88 | $4.71 | 647,200 | |
| $4.78 | +0.07 | +1.5% | $4.85 | $4.90 | $4.691 | 904,000 | |
| $4.71 | -0.44 | -8.5% | $5.15 | $5.15 | $4.71 | 1,691,100 | |
| $5.15 | -0.14 | -2.6% | $5.27 | $5.35 | $5.13 | 671,000 | |
| $5.29 | -0.02 | -0.4% | $5.34 | $5.40 | $5.22 | 1,116,700 | |
| $5.31 | +0.19 | +3.7% | $5.07 | $5.62 | $5.04 | 1,241,800 | |
| $5.12 | +0.09 | +1.8% | $5.03 | $5.14 | $5.01 | 907,000 | |
| $5.03 | -0.13 | -2.5% | $5.13 | $5.22 | $5.025 | 817,200 | |
| $5.16 | -0.14 | -2.6% | $5.24 | $5.24 | $5.12 | 492,900 | |
| $5.30 | +0.11 | +2.1% | $5.20 | $5.34 | $5.08 | 836,100 | |
| $5.19 | +0.14 | +2.8% | $5.10 | $5.22 | $5.06 | 760,500 | |
| $5.05 | -0.15 | -2.9% | $5.13 | $5.21 | $5.04 | 671,300 | |
| $5.20 | -0.065 | -1.2% | $5.27 | $5.27 | $5.13 | 574,300 | |
| $5.265 | -0.235 | -4.3% | $5.50 | $5.50 | $5.26 | 609,200 | |
| $5.50 | +0.07 | +1.3% | $5.43 | $5.515 | $5.42 | 366,200 | |
| $5.43 | -0.04 | -0.7% | $5.46 | $5.55 | $5.35 | 906,200 | |
| $5.47 | +0.13 | +2.4% | $5.40 | $5.52 | $5.32 | 417,050 | |
| $5.34 | -0.29 | -5.2% | $5.64 | $5.64 | $5.26 | 742,955 | |
| $5.63 | +0.18 | +3.3% | $5.51 | $5.77 | $5.50 | 1,013,100 | |
| $5.45 | -0.13 | -2.3% | $5.60 | $5.68 | $5.41 | 643,200 | |
| $5.58 | -0.05 | -0.9% | $5.75 | $5.79 | $5.54 | 845,900 | |
| $5.63 | +0.06 | +1.1% | $5.57 | $5.85 | $5.56 | 738,600 | |
| $5.57 | +0.06 | +1.1% | $5.50 | $5.61 | $5.405 | 576,100 | |
| $5.51 | +0.11 | +2.0% | $5.42 | $5.65 | $5.40 | 768,300 | |
| $5.40 | +0.01 | +0.2% | $5.36 | $5.44 | $5.11 | 966,300 | |
| $5.39 | +0.39 | +7.8% | $5.14 | $5.532 | $5.042 | 1,511,200 | |
| $5.00 | -0.02 | -0.4% | $5.06 | $5.09 | $4.975 | 448,400 | |
| $5.02 | -0.05 | -1.0% | $5.03 | $5.11 | $4.915 | 727,400 | |
| $5.07 | +0.02 | +0.4% | $5.14 | $5.215 | $5.03 | 509,100 | |
| $5.05 | -0.18 | -3.4% | $5.285 | $5.38 | $5.025 | 565,900 | |
| $5.23 | +0.06 | +1.2% | $5.22 | $5.46 | $5.21 | 764,900 | |
| $5.17 | +0.115 | +2.3% | $5.11 | $5.235 | $5.065 | 858,400 | |
| $5.055 | +0.045 | +0.9% | $5.00 | $5.15 | $4.91 | 588,000 | |
| $5.01 | -0.29 | -5.5% | $5.26 | $5.29 | $4.98 | 486,100 | |
| $5.30 | +0.56 | +11.8% | $4.76 | $5.32 | $4.73 | 833,100 |
- Ticker
- NASDAQ:UNCY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 33 slides
Latest news
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
Oct 21, 2026
Closed $3.87 (+1.8%) on Oct 21, 2026
Unicycive Therapeutics Appoints Meredith Manning to Board of Directors
Oct 1, 2026
Closed $4.55 (-3.1%) on Oct 1, 2026
Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
Sep 29, 2026
Closed $4.55 (-1.9%) on Sep 29, 2026
Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 1, 2026
Closed $5.05 (-2.9%) on Sep 1, 2026
Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
Aug 12, 2026
Closed $5.39 (+7.8%) on Aug 12, 2026
Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Closed $8.17 (+2.8%) on May 12, 2026
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr 9, 2026
Closed $6.65 (+3.1%) on Apr 9, 2026
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Mar 30, 2026
Closed $6.11 (-4.4%) on Mar 30, 2026
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Feb 4, 2026
Closed $6.51 (-5.9%) on Feb 4, 2026
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Jan 29, 2026
Closed $6.67 (-5.0%) on Jan 29, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 33 slides · October 2026
Technical Presentation (June 2024)
Technical · 29 slides · Jun 25, 2024
Corporate Update (December 2022)
Corporate update · 12 slides · Dec 28, 2022
Unicycive Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 108 in all · newest Oct 21, 2026 · oldest 2021
- Decks
- 3 decks · latest October 2026
Where Unicycive Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:UNCY · Home listing · This page | NASDAQ | United States | USD |
| BOATS:UNCY | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Unicycive Therapeutics, Inc.